The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Clearside Biomedical's share price is $1.415.
Clearside Biomedical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.14. Hence, Clearside Biomedical's PS Ratio for today is 10.40.
Good Sign:
Clearside Biomedical Inc stock PS Ratio (=9.93) is close to 1-year low of 9.19
The historical rank and industry rank for Clearside Biomedical's PS Ratio or its related term are showing as below:
CLSD'
s PS Ratio Range Over the Past 10 Years
Min: 2.47 Med: 71.9 Max: 9690
Current: 10.41
During the past 11 years, Clearside Biomedical's highest PS Ratio was 9690.00. The lowest was 2.47. And the median was 71.90.
CLSD's PS Ratio is ranked worse than 52.3% of 1000
companies
in the Biotechnology industry
Industry Median: 9.055
vs CLSD: 10.41
Clearside Biomedical Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Clearside Biomedical was 806.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -7.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 91.10% per year.
During the past 11 years, Clearside Biomedical's highest 3-Year average Revenue per Share Growth Rate was 690.50% per year. The lowest was -27.20% per year. And the median was 12.50% per year.
Back to Basics: PS Ratio
Clearside Biomedical PS Ratio Historical Data
The historical data trend for Clearside Biomedical's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Clearside Biomedical's PS Ratio
For the Biotechnology subindustry, Clearside Biomedical's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clearside Biomedical's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Clearside Biomedical's PS Ratio distribution charts can be found below:
* The bar in red indicates where Clearside Biomedical's PS Ratio falls into.
Clearside Biomedical PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Clearside Biomedical's Share Price of today is $1.415. Clearside Biomedical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Clearside Biomedical (NAS:CLSD) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Clearside Biomedical PS Ratio Related Terms
Thank you for viewing the detailed overview of Clearside Biomedical's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Clearside Biomedical (Clearside Biomedical) Business Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLSD has been successfully added to your 